IFNA1 and systemic lupus erythematosus: The majority of patients with SLE display overactivation of the type I IFN system, a so-called type I IFN signature, indicated by increased serum level of IFN-α and expression of type I IFN-stimulated genes (ISGs), which correlates with SLE activity and severity (1).